Erectile dysfunction is common following radical prostatectomy for localized prostate cancer, but there are indications that early pharmacological intervention could promote return of erectile function. The authors discuss preliminary results with postoperative prophylactic erectile therapy, the rationale behind such an approach, and its potential role in clinical practice.
- Alberto Briganti
- Francesco Montorsi
